Inside the Data: How SlimSEB™ Performs Under Real Digestive Conditions

Inside the Data: How SlimSEB™ Performs Under Real Digestive Conditions

If you caught our previous post about SlimSEB™^‡, you already know it is grounded in a foundation of science to support metabolic health, for everyone from biohackers tracking each glucose spike to women navigating the metabolic shifts of perimenopause and menopause.

Quick recap for anyone joining the SlimSEB™ story here: sugar is made up of two molecules, glucose and fructose. During digestion, a proprietary enzyme in SlimSEB™ steps in before all of these molecules can be absorbed by the body.

Instead of releasing all of the glucose for rapid absorption, SlimSEB™ links glucose molecules together into alternan fibers, slowly digestible and non-digestible fibers the body can’t fully break down.*

The result: A portion of ordinary dietary sugar gets converted into functional fiber before it ever reaches the bloodstream.*

So, what does that look like in the data? A new set of studies on SlimSEB™ answers this question, with a rigorous look at how it behaves during digestion and how it performs in real human trials.

In Vitro Study: What Happens During Digestion

To test what SlimSEB™ actually does to sugar, researchers used the INFOGEST protocol, a globally recognized method for simulating human digestion outside the body.

The study used a bread-and-chicken-patty sandwich with fries, soft drink and soft serve as the test meal to reflect a realistic food matrix. Researchers ran the digestion simulation both with and without SlimSEB™ and then measured the amount of simple sugar released.

Results were striking: a 34% reduction in available simple sugars following digestion!*

SlimSEB™ delivered this reduction by converting simple sugars into oligosaccharides, compounds with dietary fiber-like properties that offer prebiotic benefits and support satiety.*

For formulators, this matters because it shows SlimSEB™ works at the mechanistic level. SlimSEB™ changes the composition of what reaches the bloodstream.*

Clinical Study: Does It Hold Up in People?

Lab results only tell part of the story, so researchers followed up with a clinical trial to see whether the same effect held up in real people.

The design was rigorous:

• Double-blind, randomized, crossover, placebo-controlled
• 35 participants
• Inclusion criteria: HbA1c range 5.7-6.4
• Each participant received either SlimSEB™ or a placebo, separated by a washout period
• 2 capsules taken 30 minutes before the standardized meal of a bread-and-chicken-patty sandwich with fries, soft drink and soft serve

Each participant took either SlimSEB™ or a placebo before their meal, then had their blood glucose parameters tested. After a washout period, they crossed over to the other capsules before another meal and were tested again. Researchers then compared results across both conditions.

Key metrics measured:

• Timing of peak glucose
• Glucose Area Under the Curve (AUC), a standard measure of how blood sugar rises and falls after a meal

SlimSEB™ supplementation led to a 16.90% reduction in AUC compared with the placebo, pointing to a meaningful improvement in post-prandial glycemic response.*

Two additional findings stood out:

1. Insulin levels showed no significant difference between the SlimSEB™ and placebo groups, suggesting SlimSEB™ supports glucose metabolism through a distinct pathway rather than by increasing insulin secretion*

2. Safety held steady across the board, with no adverse events reported throughout the study*

Why this Combination Matters

Pairing an in vitro study with a clinical trial gives formulators something rare: a look at both the mechanism and the outcome. The digestion study explains why SlimSEB™ works. The clinical study confirms that it does.*

For brands building products around metabolic wellness, this combination offers real confidence. You’re not just adding an ingredient with a good story. You’re adding one with data behind it, from what happens in the digestive tract to what shows up in measurable blood sugar response.

One Ingredient, Many Metabolic Health Applications

Blood sugar management isn’t a niche concern anymore. It’s a fast-growing category, and SlimSEB™ is positioned to meet it from multiple angles:

• Cardiometabolic Health
  In vitro & clinical data in a single ingredient
• CGM Users (7.5 million+ worldwide)
  Addresses the exact metrics they already track – AUC & peak rise time
• Biohackers
  A measurable, data-backed addition to any metabolic stack
• Perimenopause & Menopause
  Real support through a major metabolic shift
• Blood Sugar Management
  Clinical data behind every claim for those working to stay within a healthy range

A range this broad makes SlimSEB™ more than a single-use ingredient. It’s a platform formulators can build on across an entire metabolic health line.

What’s Next

Future posts in this series will break down additional studies behind SlimSEB™. Each study adds another layer to the picture of how this revolutionary formulation performs across different areas of metabolic wellness.

Want to see how SlimSEB™ could fit into your next formulation? Reach out to our team at adm@specialtyenzymes.com or call (909) 613-1660.

‡ Previously GlucoSEB PB™